Ftse Mib
33.280,87
0,16%
DAX
19.146,17
0,76%
S&P 500
5.954,91
0,64%
NASDAQ
18.973,72
0,04%
Bitcoin
98.799,38
4,71%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Hutchmed (china) Limited (HCM) Hutchmed (china) Limited (HCM) Notizie

Hutchmed (china) Limited

HCM
281,00
-3,00 (-1,06%)
21 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
20/11/202410:30LSEG_RNSHutchmed (China) Limited Appointment of Independent..
06/11/202408:00LSEG_NONHutchmed (China) Limited Clinical Data to be Presented at..
31/10/202413:02ALNCNewsHutchmed China receives first milestone payment for Takeda..
31/10/202409:30LSEG_NONHutchmed (China) Limited First Commercial Milestone Payment
31/10/202409:30LSEG_RNSHutchmed (China) Limited Total Voting Rights
21/10/202410:30LSEG_RNSHutchmed (China) Limited Vesting of awards under the LTIP
16/10/202410:52ALNCNewsTOP NEWS: AstraZeneca's Tagrisso plus Orpathys shows..
16/10/202408:00LSEG_RNSHutchmed (China) Limited SAVANNAH: clinically meaningful..
24/9/202409:49ALNCNewsTakeda Pharmaceutical says Fruzaqla cancer drug gets Japan..
24/9/202409:00LSEG_RNSHutchmed (China) Limited Japan Approval for FRUZAQLA
09/9/202408:00LSEG_NONHutchmed (China) Limited Clinical Data to be Presented at..
30/8/202413:24ALNCNewsHutchmed "disappointed" as it withdraws fruquintinib..
30/8/202410:30LSEG_RNSHutchmed (China) Limited Total Voting Rights
30/8/202408:00LSEG_RNSHutchmed (China) Limited Update on Fruquintinib for Gastric..
22/8/202410:30LSEG_RNSHutchmed (China) Limited Standard form for notification of..
21/8/202410:30LSEG_NONHutchmed (China) Limited HUTCHMED to Host Expert Call to..
06/8/202411:00LSEG_RNSHutchmed (China) Limited LTIP and Share Option Scheme
31/7/202415:41ALNCNewsHutchmed confident of full year guidance for oncology and..
31/7/202413:00LSEG_RNSHutchmed (China) Limited 2024 Interim Results and Business..
05/7/202420:08ALNCNewsIN BRIEF: Hutchmed's tazemetostat given priority review in..
04/7/202408:00LSEG_NONHutchmed (China) Limited NDA Acceptance in China for..
28/6/202413:35LSEG_NONHutchmed (China) Limited Overseas Regulatory Announcement:..
28/6/202410:30LSEG_RNSHutchmed (China) Limited Total Voting Rights
28/6/202410:30LSEG_RNSHutchmed (China) Limited Blocklisting Six Monthly Return
26/6/202410:30LSEG_RNSHutchmed (China) Limited HUTCHMED to Announce 2024 HY..
24/6/202411:30LSEG_NONHutchmed (China) Limited Save the Date: HUTCHMED to Present..
24/6/202411:00ALNCNewsIN BRIEF: Hutchmed China notes Takeda obtains EU approval..
24/6/202408:00LSEG_RNSHutchmed (China) Limited European Commission Approval for..
17/6/202411:32ALNCNewsHutchmed celebrates "promising" results for sovleplenib in..
17/6/202408:00LSEG_NONHutchmed (China) Limited Lancet Publish Phase III ESLIM-01..
07/6/202419:13ALNCNewsIN BRIEF: Hutchmed (China) begins trial of menin inhibitor..
07/6/202408:00LSEG_NONHutchmed (China) Limited HUTCHMED Initiates Phase I Trial of..
03/6/202408:00LSEG_NONHutchmed (China) Limited Nature Medicine Publish Phase III..
31/5/202410:30LSEG_RNSHutchmed (China) Limited Total Voting Rights
24/5/202408:00LSEG_NONHutchmed (China) Limited HUTCHMED Presentations at 2024 ASCO..
17/5/202418:58ALNCNewsIN BRIEF: Hutchmed China Simon To leaves role, succeeded by..
17/5/202416:00LSEG_RNSHutchmed (China) Limited Retirement of Chairman and new..
17/5/202408:00LSEG_NONHutchmed (China) Limited HUTCHMED Data to be Presented at..
14/5/202415:33ALNCNewsHutchmed announces trials of HMPL-306 and Surufatinib cancer..
14/5/202408:00LSEG_NONHutchmed (China) Limited HUTCHMED Initiates Registrational..
14/5/202408:00LSEG_NONHutchmed (China) Limited HUTCHMED Initiates Phase II/III..
10/5/202414:00LSEG_RNSHutchmed (China) Limited Result of AGM
08/5/202410:30LSEG_RNSHutchmed (China) Limited Directorate Change
26/4/202417:09ALNCNewsHutchmed notes CHMP's positive opinion for fruiquintinib..
26/4/202414:30LSEG_RNSHutchmed (China) Limited Positive CHMP Opinion for..
22/4/202410:30LSEG_RNSHutchmed (China) Limited Vesting of Awards Under the LTIP
08/4/202410:30LSEG_RNSHutchmed (China) Limited 2023 Annual Report and Notice of..
05/4/202410:30LSEG_NONHutchmed (China) Limited Data to be Presented at AACR..
02/4/202411:32ALNCNewsHutchmed endometrial cancer treatment application accepted..
02/4/202408:00LSEG_NONHutchmed (China) Limited HUTCHMED and Innovent Announce NDA..
Apertura: 282,00 Min: 276,00 Max: 282,00
Chiusura: 284,00

La tua Cronologia

LSE
HCM
Hutchmed (china)
DBI
ZK2J
LevDAX x10 Price Return ...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network